IDT Supports the qPCR Community
News Jun 26, 2012
Integrated DNA Technologies (IDT) continues to provide support for life science applications with its latest successful webinar.
Over 1300 researchers registered for the live webinar entitled ‘State-of-the-art normalization of RT-qPCR data’, presented by Dr Jo Vandesompele, professor of functional genomics and applied bioinformatics at Ghent University and co-founder of real-time PCR company Biogazelle.
His expertise in the qPCR area includes numerous publications on normalization of gene expression and real-time PCR data analysis.
Available to view online, on-demand, the webinar addresses the potential pitfalls encountered when setting up a qPCR experiment. Without appropriate controls and data normalization, results can become inaccurate and misleading.
Dr Vandesompele therefore looked at the validation and selection of suitable reference genes, as well as the use of the global mean normalization method to obtain accurate data.
As a result, users can be confident in the reliability and repeatability of their amplifications. As a co-author of the MIQE guidelines, attendees benefited from Dr Vandesompele’s expertise and he was happy to answer any questions at the end of the talk.
Reinforcing the messaging of this webinar, IDT has released a free-to-download qPCR Application Guide, which provides valuable information on experimental overview, protocols, and troubleshooting.
With a dedication to developing innovative new products across qPCR, synthetic biology, RNAi, and next generation sequencing (to name a few), IDT is committed to providing useful and informative resources.
Stephen Gunstream, Vice President of Marketing at IDT commented, “Our continual investment into customer support and service, such as the development of our quarterly newsletter DECODED and the qPCR Applications Guide, has enabled us to really engage with our customers in a meaningful way - and this success has definitely been reflected in the number of registrants to this webinar. As a renowned expert within the field of qPCR, we were delighted to have Dr Vandesompele contribute not only to the recently updated qPCR Application Guide, but also in the presentation of this webinar.”
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.